Table 2.
Detail of vascular events in the 90 days of exposure for the triptans and control groups
| Triptan group (n = 24 774) |
Control group (n = 99 096) |
P value | |
|---|---|---|---|
| Number of vascular events, n (%) | 163 (0.66) | 523 (0.53) | |
| Acute cardiac events, n (%) | 75 (0.30) | 240 (0.24) | 0.43 |
| Angina pectoris | 45 | 171 | |
| Acute myocardial infarction | 20 | 52 | |
| Other acute ischemic heart diseases | 10 | 17 | |
| Acute cerebral events, n (%) | 68 (0.27) | 146 (0.15) | 0.0009 |
| Cerebral infarction | 51 | 101 | |
| Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction | 12 | 37 | |
| Stroke, not specified as haemorrhage or infarction | 5 | 8 | |
| Other vascular events, n (%) | 20 (0.08) | 137 (0.13) | 0.0002 |
| Arterial embolism and thrombosis | 17 | 121 | |
| Other retinal vascular occlusions | 1 | 3 | |
| Acute vascular disorders of intestine | 1 | 9 | |
| Other peripheral vascular diseases | 1 | 4 |